美国子宫移植与妊娠代孕治疗绝对子宫因素不孕的成本效果分析
本研究从美国医疗保健部门视角开展决策分析,比较妊娠代孕与子宫移植实现一次或两次单胎分娩的成本效果。结果显示,单胎分娩时妊娠代孕更具成本效果;双胎分娩时子宫移植绝对成本更低,在支付意愿为15万美元/QALY时子宫移植有62%的概率具成本效果。
要点
- 单胎分娩时妊娠代孕总成本为97,712.90美元,低于子宫移植的116,137.20美元。
- 单胎分娩时妊娠代孕的QALY为0.93,高于子宫移植的0.90;活产率分别为94%与77%。
- 双胎分娩时子宫移植总成本为164,276.84美元,较妊娠代孕的186,278.56美元低14%。
核心结论
- 在美国,对于仅生育一个孩子的患者,妊娠代孕可能是治疗子宫因素不孕最具成本效果的方式。
- 对于生育两个活产单胎的患者,子宫移植相关的绝对成本比妊娠代孕低14%。
研究设计与样本
- 研究设计为决策分析,视角为美国医疗保健部门,时间范围为实现一次或两次单胎分娩。
- 研究对象为希望组建家庭的子宫因素不孕患者,暴露因素为妊娠代孕或子宫移植。
- 主要结局指标为增量成本效果比,比较成本(2020年美元)与效果(质量调整生命年[QALYs]和活产)。
主要发现
- 单胎分娩基础案例中,妊娠代孕总成本为97,712.90美元(56,985.20-153,084.20美元),子宫移植后为116,137.20美元(67,142.88-182,290.86美元)。
- 单胎分娩时妊娠代孕组QALY为0.93,高于子宫移植组的0.90;活产率妊娠代孕组为94%,高于子宫移植组的77%。
- 双胎分娩时妊娠代孕总成本为186,278.56美元(103,597.81-296,010.27美元),子宫移植后为164,276.84美元(111,961.91-229,394.43美元)。
- 双胎分娩时妊娠代孕组QALY为0.93,高于子宫移植组的0.89;两次活产率妊娠代孕组为86%,高于子宫移植组的66%。
- 蒙特卡洛模拟显示,在支付意愿为150,000美元/QALY时,单胎分娩子宫移植具成本效果的概率为37%,双胎分娩为62%。
关键数值与推荐
- 单胎分娩时妊娠代孕组总成本为97,712.90美元,子宫移植组为116,137.20美元。
- 双胎分娩时妊娠代孕组总成本为186,278.56美元,子宫移植组为164,276.84美元,子宫移植较妊娠代孕低14%。
- 单胎分娩时妊娠代孕组活产率为94%,子宫移植组为77%;双胎分娩时分别为86%与66%。
- 支付意愿为150,000美元/QALY时,单胎分娩子宫移植具成本效果的概率为37%,双胎分娩为62%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the cost-effectiveness of treatment for patients with absolute uterine factor infertility to achieve one or two singleton births by gestational carrier vs. uterus transplant. DESIGN: Decision analysis from the US healthcare sector perspective, with time horizons to achieve one or two singleton births. SUBJECTS: Patients with uterine factor infertility desiring family building. EXPOSURE: Gestational carrier or uterus transplant. MAIN OUTCOME MEASURES: Incremental cost-effectiveness ratios, comparing the costs (2020 US Dollars) and effectiveness (quality-adjusted life years [QALYs] and live births) to achieve one or two births by gestational carrier vs. uterus transplant. RESULTS: In the base case of one singleton birth, the overall cost using a gestational carrier was $97,712.90 ($56,985.20-$153,084.20) compared with $116,137.20 ($67,142.88-$182,290.86) after uterus transplant. Quality-adjusted life years were higher in the gestational carrier arm (0.93) compared with the uterus transplant (0.90) and overall rates of live birth were also higher in the gestational carrier arm (94%) compared with the uterus transplant arm (77%). Costs of the gestational carrier and uterus transplant recipient were the most significant cost variables in the model. Monte Carlo simulation showed that uterus transplant had a 37% chance of being the cost-effective strategy for a single live birth at a willingness to pay of $150,000/QALY. In the case of two singleton births, the cost using a gestational carrier was $186,278.56 ($103,597.81-$296,010.27) compared with $164,276.84 ($111,961.91-$229,394.43) after uterus transplant. Quality-adjusted life years were again higher in the gestational carrier arm (0.93) than the uterus transplant (0.89). Overall rates of two live births were also higher in the gestational carrier arm (86%) compared with the uterus transplant arm (66%). Monte Carlo simulation showed that uterine transplant has a 62% chance of being the cost-effective strategy for two live births at a willingness to pay $150,000/QALY. CONCLUSION: In the United States, treatment of uterine factor infertility with a gestational carrier is likely the most cost-effective approach for patients delivering a single child. However, the absolute costs associated with uterus transplants were 14% less than a gestational carrier for those having two live singleton births.
引用
- Walter JR, Richards EG, Johannesson L, et al. Cost-effectiveness analysis of uterus transplantation vs. gestational carrier for treatment of absolute uterine factor infertility in the United States. Fertil Steril. 2025. PMID: 39848423. doi:10.1016/j.fertnstert.2025.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。